Acute Psychosis |
- Delusions, hallucinations, disorganized thinking, and behavioral disturbances.
- Agitation, aggression, and inability to engage in reality-based conversation.
- Causes may include schizophrenia, bipolar disorder, severe depression, or substance misuse.
|
- Clinical assessment, including mental state examination (MSE).
- Toxicology screen to rule out substance misuse.
- Blood tests (e.g., FBC, U&Es, LFTs) to exclude metabolic causes or medication side effects.
- CT or MRI brain scan if organic causes are suspected (e.g., head injury, tumour).
|
- Administration of antipsychotic medication (e.g., haloperidol, olanzapine).
- Consider benzodiazepines (e.g., lorazepam) for severe agitation.
- Admit to a psychiatric unit for further assessment and management.
- Use the Mental Health Act if patient lacks capacity and poses risk to self or others.
|
Suicidal Ideation or Attempt |
- Expressed intent to harm or kill oneself, or recent suicide attempt.
- May present with low mood, hopelessness, social withdrawal, and self-harm.
- Common in severe depression, bipolar disorder, personality disorders, and after traumatic events.
|
- Comprehensive psychiatric assessment, including suicide risk assessment.
- Physical examination to identify injuries or signs of self-harm.
- Blood tests and toxicology screen if overdose or poisoning is suspected.
|
- Immediate safety measures, such as constant observation and removing means of harm.
- Admission to hospital (psychiatric or general) based on severity and risk.
- Initiate antidepressant treatment if indicated and provide psychological support.
- Crisis intervention and referral to community mental health services for ongoing support.
|
Acute Mania |
- Elevated or irritable mood, increased energy, decreased need for sleep, and impulsive behavior.
- Grandiosity, racing thoughts, pressured speech, and poor judgment.
- Associated with bipolar disorder, substance misuse, or other psychiatric conditions.
|
- Clinical assessment, including mental state examination (MSE).
- Toxicology screen to rule out substance-induced mania.
- Blood tests (e.g., thyroid function tests) to rule out metabolic causes.
|
- Initiate mood stabilizers (e.g., lithium, valproate) or antipsychotics (e.g., olanzapine).
- Benzodiazepines (e.g., lorazepam) for short-term sedation and agitation management.
- Admit to a psychiatric unit for stabilization and monitoring.
|
Neuroleptic Malignant Syndrome (NMS) |
- Hyperthermia, muscle rigidity, altered mental status, and autonomic instability (e.g., tachycardia, labile blood pressure).
- Associated with the use of antipsychotic medications, especially high-potency neuroleptics.
|
- Clinical diagnosis based on presentation and antipsychotic use.
- Blood tests showing elevated creatine kinase (CK), leukocytosis, and renal impairment.
|
- Discontinue antipsychotic medication immediately.
- Supportive care, including IV fluids, cooling measures, and management of complications.
- Consider dantrolene, bromocriptine, or amantadine in severe cases.
- Admit to ICU for close monitoring if condition is severe.
|
Serotonin Syndrome |
- Agitation, confusion, myoclonus, hyperreflexia, and autonomic instability (e.g., tachycardia, hyperthermia).
- May also present with tremor, diarrhoea, and sweating.
- Often occurs after initiation or overdose of serotonergic drugs (e.g., SSRIs, MAOIs, MDMA).
|
- Clinical diagnosis based on presentation and serotonergic drug use.
- No specific diagnostic tests, but blood tests may show elevated CK and metabolic acidosis.
|
- Immediate discontinuation of serotonergic drugs.
- Supportive care, including IV fluids, benzodiazepines for agitation, and cooling measures for hyperthermia.
- Consider cyproheptadine (a serotonin antagonist) in moderate to severe cases.
|
Alcohol Withdrawal Delirium (Delirium Tremens) |
- Agitation, confusion, hallucinations, tremors, and autonomic instability (e.g., tachycardia, hypertension).
- Occurs 48-72 hours after the last alcohol intake in dependent individuals.
|
- Clinical diagnosis based on history and presentation.
- Blood tests including electrolytes, magnesium, and liver function tests.
|
- Benzodiazepines (e.g., diazepam, lorazepam) for symptom control.
- Thiamine supplementation to prevent Wernicke’s encephalopathy.
- IV fluids and correction of electrolyte imbalances.
|
Violent or Aggressive Behaviour |
- Physical aggression, verbal threats, and agitation, posing a risk to self or others.
- Often associated with acute psychosis, substance misuse, personality disorders, or delirium.
|
- Clinical assessment focusing on cause of aggression.
- Toxicology screen to rule out substance misuse.
- Blood tests to identify metabolic or neurological contributors.
|
- De-escalation techniques, including verbal calming.
- Rapid tranquilization (e.g., intramuscular lorazepam, haloperidol) if necessary.
- Use of the Mental Health Act if the patient lacks capacity and poses a risk.
|